For more than 75 years, Grifols has been improving the health and well-being of people. Our patients are our priority, and our commitment to their health has enabled us to become a global healthcare leader with presence in more than 100 countries. The Grifols legacy embodies a spirit of innovation and a forward thinking approach and establish us as an international benchmark in the plasma collection market, the production of plasma derived therapies and transfusion medicine.
Grifols has three business divisions:
Bioscience brings together all plasma related activities including research, development, collection, production and sales of life-saving plasma derived therapies. Diagnostic provides innovative solutions to support safe and compatible transfusions, monitor therapies, and detect infectious and autoimmune diseases. Research novel technologies to further improve treatment outcomes and laboratory efficiency. Hospital specializes in non-biological pharmaceutical products. This division supplies hospitals with a wide range of pharmaceutical products and medical devices for use in hospital pharmacy, automated compounding, clinical nutrition and fluid therapy.

Company Growth (employees)
Type
Public
HQ
Sant Cugat Del Vallès, ES
Founded
1940
Size (employees)
16,808 (est)
Grifols was founded in 1940 and is headquartered in Sant Cugat del Vallès, ES

Grifols Office Locations

Grifols has offices in Sant Cugat del Vallès, Clayton South, Kita Ward, Prague and in 10 other locations
Sant Cugat del Vallès, ES (HQ)
152 Avinguda de la Generalitat
Clayton South, AU
5/80 Fairbank Road
Prague, CZ
2 560 Žitná
Frankfurt am Main, DE
15 Lyoner Str.
Vicopisano, IT
15 Via Torino
Stockholm, SE
166 Sveavägen
Show all (14)

Grifols Financials and Metrics

Grifols Financials

USD

Market capitalization (02-Oct-2017)

5.7 b

Closing share price (02-Oct-2017)

21.9
Grifols's current market capitalization is $5.7 b.
Show all financial metrics

Grifols Market Value History

Grifols's Web-traffic and Trends

Grifols Online and Social Media Presence

Grifols News and Updates

Intravenous Solutions Industry: Global Market Size, Growth, Trends and 2025 Forecast Report

Intravenous Solutions market, analyzes and researches the Intravenous Solutions development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market.The provincial analysis of the worldwide Intravenous Solutions Market …

Disposable Blood Bags Market is Expected to be worth US$ 409.2 Mn by 2024

Global consumption of disposable plastic blood bags is expected to exceed 320 Mn units by 2024 end, increasing at a CAGR of 11.9% over the forecast period. Posted via Industry Today. Follow us on Twitter @IndustryToday

Disposable Plastic Blood Bags Market Demand to USD 4, 13,084.8 thousand by 2020

The global market for disposable plastic bags of blood in 2014 recorded revenues worth USD 2, 44,286.8 thousand, which are expected to raise up to USD 4, 13,084.8 thousand by the end of 2020. Over the forecast period 2014-2020, the global disposable plastic bags of blood market will expand at a heal…

Global Alpha 1 Antitrypsin Deficiency Treatment Market to Reach US$2,908.1 mn by the end of 2025

Global Alpha-1 Antitrypsin Deficiency Treatment Market: Prevalence of Respiratory Diseases Driving Demand, notes TMR Posted via Industry Today. Follow us on Twitter @IndustryToday

Global Antithrombin Market to Exceed A Value of US$704.5 mn by 2025

As per estimates presented in a report by TMR, the demand global antithrombin market will rise at a CAGR of 5.2% for the forecast period of 2017 to 2025. The market for antithrombin is predicted to attract a revenue of US$704.5 mn by the end of 2025 from US$448.2 mn in 2016. Posted via Industry Toda…

Hemostasis Diagnostics Market Expected to Cross US$3,979.5 Mn by 2025

According to the research report, the worldwide hemostasis diagnostics market is projected to attract a revenue of US$3,979.5 mn by 2025 from US$1,960.0 mn in 2016 at a CAGR of 8.3% between 2017 and 2025. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

Grifols Company Life and Culture

You may also be interested in